Park City, Utah August 14, 2026 8.0 Contract Hours $450
iForumRx is an interactive web-based community designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high-quality, practice-changing evidence. Our goal is to empower practitioners to apply the best evidence to patient care in ambulatory care settings.
Membership in the American College of Clinical Pharmacy (ACCP) or an iForumRx subscription (through ACCP) is required.
For patients with overweight or obesity and type 2 diabetes seeking weight reduction and improved glycemic control, the REDEFINE 2 study supports cagrilintide-semaglutide as an effective option. But is it better than other incretin-based therapies already available?
The recently released 2026 ACC/AHA Guideline for the Management of Dyslipidemia is a significant update. From a new atherosclerotic cardiovascular disease risk estimating tool to updated LDL-C goals for primary and secondary prevention, this new iteration brings a slew of additions and revisions.